A prospective population-based multicentre study on the impact of maternal body mass index on adverse pregnancy outcomes: Focus on normal weight

Publication date

2021-09

Authors

van Hoorn, Fieke
De Wit, LeonORCID 0000-0002-9159-8065
Van Rossem, LenieISNI 0000000387032605
Jambroes, Marielle
Groenendaal, FlorisORCID 0000-0002-9284-1637ISNI 0000000393055993
Kwee, AnnekeISNI 0000000394997376
Lamain-de Ruiter, MarijeORCID 0000-0002-5616-5686
Franx, ArieISNI 0000000396875911
van Rijn, B. B.ISNI 0000000389268638
Koster, Maria P H

Editors

Advisors

Supervisors

Document Type

Article

Collections

Open Access logo

License

cc_by

Abstract

BACKGROUND: Maternal body mass index (BMI) below or above the reference interval (18.5-24.9 kg/m2) is associated with adverse pregnancy outcomes. Whether BMI exerts an effect within the reference interval is unclear. Therefore, we assessed the association between adverse pregnancy outcomes and BMI, in particular within the reference interval, in a general unselected pregnant population. METHODS: Data was extracted from a prospective population-based multicentre cohort (Risk Estimation for PrEgnancy Complications to provide Tailored care (RESPECT) study) conducted between December 2012 to January 2014. BMI was studied in categories (I: <18.5, II: 18.5-19.9, III: 20.0-22.9, IV: 23.0-24.9, V: 25.0-27.4, VI: 27.5-29.9, VII: >30.0 kg/m2) and as a continuous variable within the reference interval. Adverse pregnancy outcomes were defined as composite endpoints for maternal, neonatal or any pregnancy complication, and for adverse pregnancy outcomes individually. Linear trends were assessed using linear-by-linear association analysis and (adjusted) relative risks by regression analysis. RESULTS: The median BMI of the 3671 included women was 23.2 kg/m2 (IQR 21.1-26.2). Adverse pregnancy outcomes were reported in 1256 (34.2%). Linear associations were observed between BMI categories and all three composite endpoints, and individually for pregnancy-induced hypertension (PIH), preeclampsia, gestational diabetes mellitus (GDM), large-for-gestational-age (LGA) neonates; but not for small-for-gestational-age neonates and preterm birth. Within the reference interval, BMI was associated with the composite maternal endpoint, PIH, GDM and LGA, with adjusted relative risks of 1.15 (95%CI 1.06-1.26), 1.12 (95%CI 1.00-1.26), 1.31 (95%CI 1.11-1.55) and 1.09 (95%CI 1.01-1.17). CONCLUSIONS: Graded increase in maternal BMI appears to be an indicator of risk for adverse pregnancy outcomes even among women with a BMI within the reference interval. The extent to which BMI directly contributes to the increased risk in this group should be evaluated in order to determine strategies most valuable for promoting safety and long-term health for mothers and their offspring.

Keywords

General

Citation

van Hoorn, F, de Wit, L, van Rossem, L, Jambroes, M, Groenendaal, F, Kwee, A, Lamain-de Ruiter, M, Franx, A, van Rijn, B B, Koster, M P H & Bekker, M N 2021, 'A prospective population-based multicentre study on the impact of maternal body mass index on adverse pregnancy outcomes : Focus on normal weight', PLoS ONE, vol. 16, no. 9 September, e0257722. https://doi.org/10.1371/journal.pone.0257722